Alvotech
ALVONASDAQHealthcare● Active
$3.94
+$0.40(+11.30%)
Market Cap$1.2B
P/E Ratio—
52W High$11.12
52W Low$2.94
Alvotech (ALVO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ALVO · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.59B | $0.49B | $0.09B | $0.08B | $0.04B |
| Cost of Revenue | $0.24B | $0.19B | $0.16B | $0.06B | $0.00B |
| Gross Profit | $0.35B | $0.30B | ($0.07B) | $0.02B | $0.04B |
| Gross Margin %(computed) | 59.82% | 62.16% | -75.93% | 22.80% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.18B | $0.17B | $0.21B | $0.18B | $0.19B |
| G&A Expenses | $0.09B | $0.06B | $0.07B | $0.19B | $0.08B |
| Total Operating Expenses | $0.27B | $0.23B | $0.29B | $0.37B | $0.27B |
| Operating Income | $0.08B | $0.07B | ($0.35B) | ($0.35B) | ($0.24B) |
| Operating Margin %(computed) | 13.34% | 14.22% | -388.11% | -417.25% | -640.31% |
| Interest Income | $0.20B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.15B | $0.16B | $0.13B | $0.09B | $0.11B |
| Income Before Tax | $0.14B | ($0.22B) | ($0.65B) | ($0.55B) | ($0.15B) |
| Income Tax Expense | $0.11B | $0.01B | ($0.10B) | ($0.04B) | ($0.05B) |
| Net Income | $0.03B | ($0.23B) | ($0.55B) | ($0.51B) | ($0.10B) |
| Net Margin %(computed) | 4.76% | -47.35% | -603.42% | -618.55% | -276.04% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.10 | $-0.87 | $-2.43 | $-2.60 | $-3.25 |
| Wtd Avg Shares | 0.28B | 0.27B | 0.23B | 0.20B | 0.03B |
| EBITDA | $0.32B | ($0.03B) | ($0.49B) | ($0.44B) | ($0.02B) |
| EBITDA Margin %(computed) | 55.16% | -6.59% | -539.92% | -529.69% | -49.03% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Alvotech data
About Alvotech (ALVO) Income Statement
Alvotech (ALVO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ALVO reported revenue of $0.59B, gross profit of $0.35B (gross margin 59.82%), and net income of $0.03B — a net profit margin of 4.76%.
Frequently asked questions
ALVO · 4 questionsAlvotech (ALVO) reported revenue of $0.59B for 2025, up 19.7% year-over-year.
ALVO revenueALVO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08